IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

GUERINI ROCCO, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2151
NA - Nord America 2055
AS - Asia 761
OC - Oceania 18
AF - Africa 12
SA - Sud America 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5010
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1990
GB - Regno Unito 988
CN - Cina 505
IT - Italia 404
SE - Svezia 225
IE - Irlanda 172
DE - Germania 82
FR - Francia 78
IN - India 71
CA - Canada 60
DK - Danimarca 49
JP - Giappone 38
KR - Corea 34
UA - Ucraina 33
TR - Turchia 28
BE - Belgio 25
ID - Indonesia 22
AU - Australia 18
TW - Taiwan 17
NL - Olanda 15
CH - Svizzera 13
ES - Italia 12
FI - Finlandia 11
HK - Hong Kong 11
RU - Federazione Russa 8
AT - Austria 7
PH - Filippine 7
PL - Polonia 7
VN - Vietnam 7
UZ - Uzbekistan 6
BR - Brasile 5
EG - Egitto 5
NO - Norvegia 5
PT - Portogallo 4
RO - Romania 4
CZ - Repubblica Ceca 3
GR - Grecia 3
MY - Malesia 3
SC - Seychelles 3
CI - Costa d'Avorio 2
EU - Europa 2
IQ - Iraq 2
MX - Messico 2
PE - Perù 2
TH - Thailandia 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CL - Cile 1
CO - Colombia 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LT - Lituania 1
PA - Panama 1
PK - Pakistan 1
SG - Singapore 1
VE - Venezuela 1
Totale 5012
Salva come PNG Salva come JPEG
Città #
Southend 937
Chandler 325
Fairfield 220
Milan 199
Dublin 168
Princeton 159
Wilmington 133
Woodbridge 107
Ann Arbor 102
Seattle 100
Houston 87
Cambridge 86
Ashburn 85
Dearborn 77
Beijing 55
Des Moines 54
Nanjing 46
Toronto 46
Jinan 39
Shenyang 38
Redwood City 30
Shanghai 29
Guangzhou 27
Changsha 26
San Diego 25
Brussels 22
Phoenix 22
Seoul 21
Hebei 19
Tokyo 19
Berlin 18
Nanchang 18
Boardman 15
Hangzhou 14
Silver Spring 14
Grafing 13
Zhengzhou 12
London 11
Upper Marlboro 11
Chengdu 10
Falls Church 10
Istanbul 10
Medford 10
Tianjin 10
Mountain View 9
Redmond 9
Jiaxing 8
Rho 8
Boston 7
Chicago 7
Fremont 7
Haikou 7
San Francisco 7
Taizhou 7
Central District 6
Dalmine 6
Taipei 6
Costa Mesa 5
Dong Ket 5
Fuzhou 5
Jacksonville 5
Ottawa 5
Rome 5
São Paulo 5
Andover 4
Edinburgh 4
Göteborg 4
New York 4
Norwalk 4
Roxbury 4
Taiyuan 4
Turin 4
Wuhan 4
Alpedrete 3
Athens 3
Atlanta 3
Barcelona 3
Bengaluru 3
Chongqing 3
Cinisello Balsamo 3
Harbin 3
Kochi 3
Kunming 3
Los Angeles 3
Mahé 3
Ningbo 3
Paris 3
Somerville 3
Southampton 3
Warsaw 3
Xian 3
Abidjan 2
Amsterdam 2
Ankara 2
Baltimore 2
Bergen 2
Bordeaux 2
Buttapietra 2
Cesena 2
Clayton 2
Totale 3716
Salva come PNG Salva come JPEG
Nome #
Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma 243
Schwann cell hamartoma: case report 230
Efficacy of Anti-PD1/PD-L1 Therapy (IO) in KRAS Mutant Non-small Cell Lung Cancer Patients : a retrospective analysis 168
The contrasting role of p16Ink4A patterns of expression in neuroendocrine and non-neuroendocrine lung tumors : a comprehensive analysis with clinicopathologic and molecular correlations 163
An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper® 142
HER2 in gastric cancer : a digital image analysis in pre-neoplastic, primary and metastatic lesions 141
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence 134
Targeting immune-related biological processes in solid tumors : we do need biomarkers 125
Molecular Profile of Advanced Non-Small Cell Lung Cancers in Octogenarians: The Door to Precision Medicine in Elderly Patients 121
Circulating and tissue biomarkers in early-stage non-small cell lung cancer 119
The oncofetal protein IMP3 : a useful marker to predict poor clinical outcome in neuroendocrine tumors of the lung 111
SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma 109
Contrast-enhanced computed tomography colonography in preoperative distinction between T1-T2 and T3-T4 staging of colon cancer 99
Lymphovascular invasion and extranodal tumour extension are risk indicators of breast cancer related lymphoedema: An observational retrospective study with long-term follow-up 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis 97
Liver toxicity in the era of immune checkpoint inhibitors: A practical approach 97
Pten alterations and their role in cancer management: Are we making headway on precision medicine? 96
E-cadherin deregulation in breast cancer 93
Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy 91
Immunotherapy in breast cancer patients: A focus on the use of the currently available biomarkers in oncology 91
Comprehensive genomic analysis reveals the prognostic role of LRRK2 copy-number variations in human malignancies 87
Hereditary gastric and breast cancer syndromes related to CDH1 germline mutation: A multidisciplinary clinical review 86
IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypes 84
Mismatch repair-deficient hormone receptor-positive breast cancers : Biology and pathological characterization 83
Emergency Lung Transplantation after {COVID}-19: Immunopathological Insights on Two Affected Patients 83
Digital Pathology and PD-L1 Testing in Non Small Cell Lung Cancer: A Workshop Record 80
Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer : Results from the SOLE Trial 74
Acquired Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancers : the Role of Next-Generation Sequencing on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Samples 71
Rediscovering secondary tumors of the prostate in the molecular era 69
Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer 66
Dynamic retention of Ero1α and Ero1β in the endoplasmic reticulum by interactions with PDI and ERp44 66
Hibernation in Unusual Places: A Pure Typical Hibernoma of the Breast 64
Microglandular adenosis associated with triple-negative breast cancer is a neoplastic lesion of triple-negative phenotype harbouring TP53 somatic mutations 64
The birth of an adenoid cystic carcinoma 63
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast : an exploratory, hypothesis-generating study 62
Successful treatment with avapritinib in patient with mucosal metastatic melanoma 62
Are acinic cell carcinomas of the breast and salivary glands distinct diseases? 61
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00 60
Histologically-Proven Efficacy of Bland Embolization in a Patient with Net Liver Metastasis 59
Understanding EGFR heterogeneity in lung cancer 53
Early Breast Cancers During Pregnancy Treated With Breast-Conserving Surgery in the First Trimester of Gestation: A Feasibility Study 52
Premalignant and pre-invasive lesions of the breast 51
Broad-based genomic sequencing in advanced non-small cell lung cancer in the dock 51
Digital slides as an effective tool for programmed death ligand 1 combined positive score assessment and training: Lessons learned from the 'Programmed death ligand 1 key learning program in Head-and-Neck squamous cell carcinoma' 51
Recurrent NAB2-STAT6 gene fusions and oestrogen receptor-α expression in pulmonary adenofibromas 49
The genetic landscape of breast carcinomas with neuroendocrine differentiation 49
A role for the immune system in advanced laryngeal cancer 49
Small cell carcinoma of the gynecologic tract : a multifaceted spectrum of lesions 48
Targeting EGFR T790M mutation in NSCLC : from biology to evaluation and treatment 48
Pharmacological management of male breast cancer 48
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. : Clinical outcome and actionable molecular alterations 47
PI3K pathway activation in high-grade ductal carcinoma in situ-implications for progression to invasive breast carcinoma 45
Lobular carcinoma in situ : a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk 45
Multicenter Comparison of 22C3 PharmDx (Agilent) and SP263 (Ventana) Assays to Test PD-L1 Expression for NSCLC Patients to Be Treated with Immune Checkpoint Inhibitors 43
Letter to the Editor 43
Integrated analysis of mismatch repair, PD-L1, and immune microenvironment status in pregnancy-associated breast cancers 43
Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis 42
High-risk human papillomavirus in anal squamous cell carcinoma : a 'conservative' leading role 39
Complex differential diagnosis between primary breast cancer and breast metastasis from egfr-mutated lung adenocarcinoma: Case report and literature review 39
ROS1 Gene Fusion in Advanced Lung Cancer in Women : A Systematic Analysis, Review of the Literature, and Diagnostic Algorithm 38
Reproducibility of mrna-based testing of esr1, pgr, erbb2, and mki67 expression in invasive breast cancer—a europe-wide external quality assessment 38
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancer 37
Whole-Exome and RNA-Sequencing Analyses of Acinic Cell Carcinomas of the Breast 37
Proposal for integrating the pathologic assessment of lymphovascular invasion and extranodal tumor extension in breast cancer-related lymphedema clinical management 37
Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling 37
Looking for sputum biomarkers in lung cancer secondary prevention : where are we now? 35
Gr-MDSC-linked asset as a potential immune biomarker in pretreated NSCLC receiving nivolumab as second-line therapy 35
The Genomic Landscape of Male Breast Cancers 35
Prospective evaluation of EBUS-TBNA specimens for programmed death-ligand 1 expression in non-small cell lung cancer patients : a pilot study 35
The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics 31
Inter-tumor genomic heterogeneity of breast cancers : comprehensive genomic profile of primary early breast cancers and relapses 30
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer : a study of the Italian NGS Network 28
Standard operating procedures for biobank in oncology 27
Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages 26
Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis 24
Next-generation sequencing-based BRCA testing on cytological specimens from ovarian cancer ascites reveals high concordance with tumour tissue analysis 20
Role and evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy: consensus statement 19
Low-risk triple-negative breast cancers: Clinico-pathological and molecular features 18
The immune profile of EGFR-mutated non-small-cell lung cancer at disease onset and progression after tyrosine kinase inhibitors therapy 17
Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles 16
Making the most of complexity to create opportunities: Comprehensive genomic profiling and molecular tumor board for patients with non-small cell lung cancer (NSCLC) 16
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis 12
Genomic characterization of concurrent alterations in non-small cell lung cancer (Nsclc) harboring actionable mutations 11
HER2 in Metastatic Colorectal Cancer: Pathology, Somatic Alterations, and Perspectives for Novel Therapeutic Schemes 10
HER2 Low, Ultra-low, and Novel Complementary Biomarkers: Expanding the Spectrum of HER2 Positivity in Breast Cancer 10
null 6
null 3
null 3
null 1
Totale 5441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10871
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201858 0000 00 00 003523
2018/2019405 99253148 635 4324 20152435
2019/2020946 1002512116 66107 11891 1451002739
2020/20211161 51759752 105106 14699 12411282112
2021/20221125 100755271 8572 7282 1349254236
2022/20231228 150121118124 105241 6375 14413740
Totale 5441